Welcome to FPMPAM

Don’t blame us for not detecting dengue in patients earlier, say docs

Published: 1 Feb 2015

 

 

PETALING JAYA: General practitioners (GPs) have objected to the view that they usually missed dengue detection on patients’ early visits, saying that the dengue rapid test should be carried out only when symptoms were suspicious.

“Even when we confirm dengue on day one, if blood pressure, platelet level and everything else is normal and we send the patient to a government hospital, they will turn away the patient,” Medical Practitioners Coalition Association of Malaysia president Dr Jim Loi said.

GPs, he said, would normally do the test on patients’ second visit.

Based on past incidents, he said patients referred to government hospitals after they were diagnosed for dengue on the second visit had been turned away when their vital readings were normal.

On Wednesday, Health Minister Datuk Seri Dr S. Subramaniam urged GPs to stock up on dengue rapid test kits as 99% of them missed the diagnosis on the first visits.

However, Dr Loi noted that cost was also a deterrent factor for many patients.

The normal rapid test cost RM30 to RM40 (NS1 antigen test) while the combo rapid test kit (IgG and IgM) cost RM80, not including consultation and medicine, he said.

“If symptoms persist after two days, we would advise them either to return to us to check for dengue or go straight to the hospital.”

He said early detection had no bearing on patient mortality as it would depend on how patients were managed as the disease progresses.

Malaysian Medical Association president Dr Krishna Kumar also said patients were not screened during early visits because it was not economically viable to do so.

“Currently, we don’t think it is necessary to do the test on the first day of fever but we tell the patients to return after two days if fever persists,” he said.

He noted that patients could miss the diagnosis if they hopped from one doctor to another.

The Federation of Private Medical Practitioners’ Associations president Dr Steven Chow said commercially available test kits could not confirm the diagnosis of dengue in the early stages of the disease.

“What is most important is a high index of suspicion for all cases and the proper use of the test at the appropriate time,” he said.

He said the decision was best left to the attending doctor to advise on adequate fluid consumption, monitor the patient regularly for danger signs and to refer problematic cases with potential complications to hospitals for further management.

“This has been the standard operating procedure recommended by the Health Ministry,” he said.

 

 

Originally published in thestar.com.my
http://www.thestar.com.my/News/Nation/2015/02/01/GPs-Test-done-on-second-visit-Dont-blame-us-for-not-detecting-dengue-in-patients-earlier-say-docs/

 

Go Back

Latest Updates

12 Aug 2018
Implementation of Data Breach Notification
Details >>

15-16 Sep 2018
2nd FPMPAM / IPH Annual Convention incorporating 1st FPMPAM Malaysian Healthcare Conference
Flyer >>

15-16 Sep 2018

1st FPMPAM Malaysian Healthcare Conference
Flyer >>

25 April 2018

Guidelines on Continuing Professional Development (CPD) for Medical Practitioners In Malaysia
Download >>

8 Mar 2018
Specialist Medical Practitioners Continuing Professional Development (CPD) Policies and Guidelines
Read >>


Recent Events

12 Aug 2018
Cardiothoracic Surgery & The General Practitioner
Flyer >>

 

15 April 2018
Medico-Legal Forum on "Medical Manslaughter - Aftershocks from Bawa Garba 2018".
Flyer >>

 

Date: 25 Nov 2017
Insight Into Clinical Radiology
Details

 

Date: 8 Oct 2017
Doctors' Day Celebration 2017
Details

 

Date: 16 & 17 Sep 2017
1st FPMPAM/IPH Annual Scientific Convention
Announcement || Souvenir Programme

 

Date: 8 & 9 Sep 2017
Nursing Conference 7.0 / Training Course for Clinic Personnel 9.0
Full details || Report

 

Latest Newsletter


go to newsletter section

 

Latest newsletter of Perak Medical Practitioners' Society
Click here >>

 

 

Resources / Links

Specialist Medical Practitioners Continuing Professional Development (CPD) Policies and Guidelines
Read >>

 

Joint Integrated Healthcare Committee (JIHC) Term Sheet
Click here >>

 

Joint Integrated Healthcare Committee (JIHC) Terms of Reference
Click here >>

 

National Pharmaceutical Regulatory Agency
Click here >>

 

NPRA: Reporting medicinal problems
Click here >>

 

Makluman Kontraindikasi Penggunaan Ubat Yang Mengandungi Codeine Untuk Kanak-Kanak Beumur Bawah 12 Tahun Dan Ibu Yang Menyusu Susulan Risiko Respiratory Depression
Click here >>

 

Peringatan: Langkah-Langkah Pengurangan Risiko Bagi Kesan Advers Kulit Tang Serius Susulan Penggunaan Allopurinol
Click here >>

 

VALPROATE
Guide for HCP >>
Patient Information >>
Sodium Valproate (Guide for HCP) >>

 

NDST Report 2011
Click here >>

 

Garis Panduan Pemantauan Keselamatan Produk ESAs dan Pelaporan Kesan Advers PRCA
Click here >>

 

Report On Suspected Adverse Drug Reactions
Click here >>

 

MADRAC KE 146 - Traditional Medicine found Adulterated
Read >>

BPFK website: Cancellation of Registered Traditional Products / Notified Cosmetics
Read >>


Pharmacy Services Division: List of Adulterated Products
Read >>

 

Pharmacy Services Division: Press Releases
Read >>